Boss David Epstein hopes to replicate his success at Seagen after $43bn sale last year
Six-fold rise in job ads that mention conditions such as ADHD and autism since 2019, data shows
In this monthly series, running alongside our existing Tech Exchange dialogues, FT journalists talk to the scientists, developers and business leaders exploring ever more applications for artificial intelligence, in every aspect of our lives
From video games to personal avatars, researchers are looking to develop a new generation of digital tools that do not involve taking a drug or therapy
This series examines how employers and governments are tackling the rise in depression and other conditions — and the new therapies being developed
In search of the ultimate bedding
Precision Neuroscience, maker of a ‘brain-computer interface’, has raised more than $100mn in latest investment round
About 12bn working days lost to depression and anxiety each year, costing global economy $1tn
The UnitedHealthcare shooting highlights the problems of a healthcare system many see as broken
Concerted action urged over potentially ‘catastrophic’ damage to humanity from manufactured bacteria
Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’s
Rival companies are racing to create lucrative applications from cutting-edge technology
Fatty molecules also found in UPFs seen at high levels in colorectal tumours
Consumers need clear information to make healthier choices about what they eat
Jubilation among some users highlights scale of Americans’ frustration over their health system
Britain’s illness-related inactivity crisis looks increasingly like a mirage
Research intensifies debate over health risks of mass-produced goods made more palatable for consumers
Unhealthy foods cannot be shown online or before 9pm under new rules to cut childhood obesity
Government-ordered report comes after FT investigation into impact of toxic metal on human health
Abingworth wants to pursue royalty-based partnerships with major pharma groups
Months of scrutiny follow landmark decision as questions remain over how it would be safely implemented
Legislators vote to allow some terminally ill people in England and Wales to end their lives
This is a time for treating people as individuals rather than as members of a tribe
Done the wrong way, it can have awkward effects
The fair’s new director Bridget Finn on selling art in a divided US. Plus: interviews with Anastasia Samoylova and Jesse Lee, the private gallery succession question
